180 related articles for article (PubMed ID: 426557)
1. Urine calcitonin as a test for medullary thyroid cancer: a new screening procedure.
Silva OL; Snider RH; Moore CF; Becker KL
Ann Surg; 1979 Mar; 189(3):269-74. PubMed ID: 426557
[TBL] [Abstract][Full Text] [Related]
2. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
3. Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland.
Wells SA; Baylin SB; Linehan WM; Farrell RE; Cox EB; Cooper CW
Ann Surg; 1978 Aug; 188(2):139-41. PubMed ID: 686877
[TBL] [Abstract][Full Text] [Related]
4. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
5. A comparison of calcium pentagastrin and TRH tests in screening for medullary carcinoma of the thyroid in MEN IIA.
O'Connell JE; Dominiczak AF; Isles CG; McLellan AR; Davidson G; Gray CE; Connell JM
Clin Endocrinol (Oxf); 1990 Apr; 32(4):417-21. PubMed ID: 1971777
[TBL] [Abstract][Full Text] [Related]
6. Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.
Wells SA; Baylin SB; Johnsrude IS; Harrington DP; Mendelsohn G; Ontjes DJ; Cooper CW
Ann Surg; 1982 Nov; 196(5):505-11. PubMed ID: 7125737
[TBL] [Abstract][Full Text] [Related]
7. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma.
Kudo T; Miyauchi A; Ito Y; Yabuta T; Inoue H; Higashiyama T; Tomoda C; Hirokawa M; Amino N
Endocr J; 2011; 58(3):217-21. PubMed ID: 21358115
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules.
Costante G; Meringolo D; Durante C; Bianchi D; Nocera M; Tumino S; Crocetti U; Attard M; Maranghi M; Torlontano M; Filetti S
J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000
[TBL] [Abstract][Full Text] [Related]
9. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer.
Colombo C; Verga U; Mian C; Ferrero S; Perrino M; Vicentini L; Dazzi D; Opocher G; Pelizzo MR; Beck-Peccoz P; Fugazzola L
J Clin Endocrinol Metab; 2012 Mar; 97(3):905-13. PubMed ID: 22170709
[TBL] [Abstract][Full Text] [Related]
10. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases.
Hahm JR; Lee MS; Min YK; Lee MK; Kim KW; Nam SJ; Yang JH; Chung JH
Thyroid; 2001 Jan; 11(1):73-80. PubMed ID: 11272100
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay.
Melvin KE; Miller HH; Tashjian AH
N Engl J Med; 1971 Nov; 285(20):1115-20. PubMed ID: 5095737
[No Abstract] [Full Text] [Related]
12. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging.
Wells SA; Baylin SB; Gann DS; Farrell RE; Dilley WG; Preissig SH; Linehan WM; Cooper CW
Ann Surg; 1978 Sep; 188(3):377-83. PubMed ID: 686900
[TBL] [Abstract][Full Text] [Related]
13. Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests.
Gharib H; Kao PC; Heath H
Mayo Clin Proc; 1987 May; 62(5):373-8. PubMed ID: 3573825
[TBL] [Abstract][Full Text] [Related]
14. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests.
Telenius-Berg M; Almqvist S; Berg B; Hedner P; Ingemansson S; Tibblin S; Wasthed B
Eur J Clin Invest; 1977 Feb; 7(1):7-16. PubMed ID: 402280
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay of urinary calcitonin in normal subjects and in patients with medullary carcinoma of the thyroid.
Morimoto S; Onishi T; Okada Y; Lee S; Imanaka S; Fukuo K; Kono H; Kumahara Y
Endocrinol Jpn; 1982 Feb; 29(1):1-10. PubMed ID: 7106058
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.
Blind E; Raue F; Klaiber T; Zink A; Schroth J; Buhr H; Ziegler R
J Endocrinol Invest; 1992 Feb; 15(2):93-8. PubMed ID: 1569295
[TBL] [Abstract][Full Text] [Related]
17. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma.
Verdy M; Cholette JP; Cantin J; Lacroix A; Sturtridge WC
Can Med Assoc J; 1978 Jul; 119(1):29-35. PubMed ID: 679097
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
19. Clinical performance of an extraction calcitonin radioimmunoassay.
Kao PC; Gharib H
Mayo Clin Proc; 1993 Dec; 68(12):1165-70. PubMed ID: 8246617
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A as tumor marker in medullary thyroid carcinoma.
Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]